In August 2016, Singapore’s sovereign wealth fund GIC sold in share deal to a French institutional investor the "Two & Only" portfolio, comprising two office buildings of exceptional standing located in the heart of Paris’ central business quarter: 1-5 rue d’Astorg (9,900 m²) and 10-16 rue de la Ville l’Evêque (14,400 m²).

Gide advised GIC on the legal aspects of the transaction, with a team comprising partner Hugues Moreau and associate Pierre-Adrien Vibert.

Mayer Brown announced today that it represented British private equity investor STAR Capital Partners on the sale of Blohm+Voss to Lürssen shipyard in Bremen. The purchase price was not disclosed. The transaction is still subject to the approval by the antitrust authorities.

Blohm+Voss is a German shipyard headquartered in Hamburg (Germany). It was founded in 1877 and currently has around 1,000 employees.

With a team led by Dr. Marc Scheunemann, Heuking Kühn Lüer Wojtek advised UK-based private equity real estate fund manager Benson Elliot on the sale of the headquarters of Berliner Volksbank in Berlin’s City West to Barings Real Estate Advisers. Barings has acquired the property by way of a share deal for a US institutional investor advised by Barings.
 

Led by CHSH partner Manfred Ton, the Real Estate & Construction team of CHSH advised IC Development on its sale of the new DENK DREI office complex, situated in the VIERTEL ZWEI, to ARE.

 „We're extremely pleased that IC Development called upon the expertise of CHSH to provide advise in connection with this transaction, which is one of the largest real estate deals of the year 2016“, said Manfred Ton.

Addleshaw Goddard's Manchester Real Estate team has advised Alderley Park on its sale of 13 acres to developer PH homes.

PH Homes plan to use the land for a development of 74 prestige family homes, which is the first residential phase of the £160m plan for the site, which will will eventually see up to 275 homes, new sports and leisure facilities, including a gastro pub, hotel and farm shop.

We assisted German company Commerz Real in their sale of a modern, LEED-certified office property built in the Sörnäinen district of Helsinki in 2009. The purchaser was Finnish real estate investor Antilooppi.

The tenants of the sold office building include the headquarters of Aspo Plc, the Finnish Tax Administration and Tommy Hilfiger. The building has a total leasable area of approximately 11,000 square meters.

With a team led by Dr. Stefan Proske, Partner at its Berlin office, Heuking Kühn Lüer Wojtek represented a syndicate of banks, led by Landesbank Hessen-Thüringen, in insolvency proceedings on the assets of Narat GmbH & Co. KG and advised it on the sale of seven office and commercial properties to EQT Real Estate.
 

Slaughter and May is advising Wing Tai Properties Limited and Nan Fung International Holdings Limited (the Sellers) in relation to the proposed sale of the entire issued share capital (and related shareholder loans) of Property Sky Limited to Natural Apex Limited, a wholly-owned subsidiary of Jingrui Holdings Limited. Subject to certain customary adjustments, the aggregate consideration for the sale of the shares and the related shareholder loans is approximately HK$915.6 million. The Target holds certain interests in a property known as "Upper Riverside" in Pudong, Shanghai.

Baker & McKenzie’s Kyiv office advised US and British investors on the sale of 100% of their shares in 1849-Apollo Overseas I Limited (Cyprus), the founder of Atlantic-Pacific Ventures LLC (Kyiv), which owns and manages the shopping center Pyramida in Kyiv, to Dragon Capital.

Baker & McKenzie’s Kyiv team was led by Kyiv Real Estate Partner Lina Nemchenko, with key input from associates Elmaz Abkhairova in Kyiv and Robert Gray in London.

Slaughter and May is advising GlaxoSmithKline plc (GSK) on a series of agreements with the Aspen Group (Aspen) as part of GSK’s strategy of simplification through focusing on core therapeutic areas. GSK will divest its anaesthesia portfolio to Aspen for £180 million plus milestones of up to £100 million. GSK and Aspen have also entered into parallel agreements to terminate their collaboration in Sub-Saharan Africa and for Aspen to exercise its option to acquire GSK’s remaining thrombosis business in certain retained markets.